Literature DB >> 33554097

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction.

Ying Shang1, Patrik Nasr2, Mattias Ekstedt2, Linnea Widman3, Per Stål4,5, Rolf Hultcrantz4,5, Stergios Kechagias2, Hannes Hagström4,5,6.   

Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is common in the general population, but its association with dementia is unclear. We aimed to assess the risk of dementia related to NAFLD, and to determine whether histological parameters could improve the predictive capacity of a conventional risk model for dementia in patients with biopsy-proven NAFLD.
METHODS: A retrospective matched cohort study of 656 NAFLD patients underwent liver biopsy at 2 hospitals between 1971 and 2009. Up to 10 individuals (controls) from the general population (n = 6,436) were matched for age, sex, and municipality to each patient. Dementia was ascertained from National registers until 2014. Using Cox regression, we estimated hazard ratios for dementia with 95% confidence intervals. In the biopsy cohort, the discriminative power of adding histological markers to a conventional risk model was assessed by Harrell's C-index and compared with a likelihood-ratio test.
RESULTS: During a mean follow-up of 19.7 ± 8.7 years, 3.3% of the NAFLD patients and 4.9% of the controls developed dementia (p = 0.07). Overall, NAFLD was not significantly associated with incident dementia. In the biopsy cohort, the model of conventional risk factors (age, sex, hypertension, and cardiovascular diseases) had a C-index of 0.912 to predict incident dementia. Adding individual histological parameters significantly increased the prediction of dementia, with the most pronounced improvement for fibrosis stage (C-index = 0.938, p <0.05).
CONCLUSIONS: Although NAFLD was not associated with the risk of dementia, we found that adding histological markers to a conventional risk model for dementia enhanced the predictive capacity, indicating a shared metabolic origin. LAY
SUMMARY: Both non-alcoholic fatty liver disease (NAFLD) and dementia are increasing in prevalence because of a more sedentary lifestyle, increased prevalence of obesity and population ageing. However, the link between these 2 diseases is not well studied. We investigated the association between NAFLD and the risk of dementia and found no association. However, liver histology parameters, especially fibrosis, could significantly improve the prediction of dementia risk.
© 2020 The Author(s).

Entities:  

Keywords:  Dementia; Histological pathology; NAFLD; Prediction

Year:  2020        PMID: 33554097      PMCID: PMC7847958          DOI: 10.1016/j.jhepr.2020.100218

Source DB:  PubMed          Journal:  JHEP Rep        ISSN: 2589-5559


  35 in total

1.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

2.  Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.

Authors:  Galit Weinstein; Kendra Davis-Plourde; Jayandra J Himali; Shira Zelber-Sagi; Alexa S Beiser; Sudha Seshadri
Journal:  Liver Int       Date:  2019-06-26       Impact factor: 5.828

Review 3.  Alzheimer´s disease and oxidative stress: a review.

Authors:  Miroslav Pohanka
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

4.  Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.

Authors:  Pierre Bedossa; Christine Poitou; Nicolas Veyrie; Jean-Luc Bouillot; Arnaud Basdevant; Valerie Paradis; Joan Tordjman; Karine Clement
Journal:  Hepatology       Date:  2012-11       Impact factor: 17.425

5.  Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors:  Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

Review 6.  Subcortical ischaemic vascular dementia.

Authors:  Gustavo C Román; Timo Erkinjuntti; Anders Wallin; Leonardo Pantoni; Helena C Chui
Journal:  Lancet Neurol       Date:  2002-11       Impact factor: 44.182

7.  Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up.

Authors:  Chris Elliott; James Frith; Christopher P Day; David E J Jones; Julia L Newton
Journal:  Dig Dis Sci       Date:  2013-04-23       Impact factor: 3.199

8.  Association of diabetes with stroke and post-stroke dementia: A population-based cohort study.

Authors:  Ying Shang; Laura Fratiglioni; Anna Marseglia; Anna Plym; Anna-Karin Welmer; Hui-Xin Wang; Rui Wang; Weili Xu
Journal:  Alzheimers Dement       Date:  2020-06-02       Impact factor: 21.566

Review 9.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

Review 10.  Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review.

Authors:  Eugene Y H Tang; Stephanie L Harrison; Linda Errington; Mark F Gordon; Pieter Jelle Visser; Gerald Novak; Carole Dufouil; Carol Brayne; Louise Robinson; Lenore J Launer; Blossom C M Stephan
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more
  7 in total

Review 1.  A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism.

Authors:  Kentaro Matsuzaki; Akira Nakajima; Yuanqiang Guo; Yasushi Ohizumi
Journal:  Nutrients       Date:  2022-04-28       Impact factor: 6.706

Review 2.  Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Cell Biosci       Date:  2022-06-28       Impact factor: 9.584

3.  Nonalcoholic Fatty Liver Disease and Altered Neuropsychological Functions in Patients with Subcortical Vascular Dementia.

Authors:  Rita Moretti; Mauro Giuffré; Lory Saveria Crocè; Silvia Gazzin; Claudio Tiribelli
Journal:  J Pers Med       Date:  2022-07-05

Review 4.  Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease.

Authors:  Liv Tybjærg Nordestgaard; Mette Christoffersen; Ruth Frikke-Schmidt
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

5.  Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.

Authors:  Seogsong Jeong; Yun Hwan Oh; Seulggie Choi; Jooyoung Chang; Sung Min Kim; Joung Sik Son; Gyeongsil Lee; Joseph C Ahn; Dong Hyeon Lee; Bo Kyung Koo; Won Kim; Sang Min Park
Journal:  Clin Mol Hepatol       Date:  2022-03-17

6.  Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Luping Wang; Bowen Sang; Zuyan Zheng
Journal:  Front Aging Neurosci       Date:  2022-09-20       Impact factor: 5.702

7.  Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study.

Authors:  Céline Ben Hassen; Aurore Fayosse; Benjamin Landré; Martina Raggi; Mikaela Bloomberg; Séverine Sabia; Archana Singh-Manoux
Journal:  BMJ       Date:  2022-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.